Scleroderma Clinical Trials

A listing of Scleroderma medical research trials actively recruiting patient volunteers. Click on the closest city to find more detailed information on a research study in your area.

 

California

Los Angeles California 90095

Patients are needed to participate in a clinical research study evaluating Abatacept and Placebo for the treatment of Diffuse Cutaneous Systemic Sclerosis

Los Angeles California 90045

Patients are needed to participate in a clinical research study evaluating Abatacept and Placebo for the treatment of Diffuse Cutaneous Systemic Sclerosis

Redwood City California 94063

Patients are needed to participate in a clinical research study evaluating Abatacept and Placebo for the treatment of Diffuse Cutaneous Systemic Sclerosis

District of Columbia

Washington District of Columbia 20009

Patients are needed to participate in a clinical research study evaluating Abatacept and Placebo for the treatment of Diffuse Cutaneous Systemic Sclerosis

Illinois

Chicago Illinois 60611

Patients are needed to participate in a clinical research study evaluating Abatacept and Placebo for the treatment of Diffuse Cutaneous Systemic Sclerosis

Massachusetts

Boston Massachusetts 02118

A Phase 1/Phase 2 clinical study for patients with Scleroderma, Systemic Sclerosis, Diffuse Scleroderma or Diffuse Systemic Sclerosis

Boston Massachusetts 02116

Patients are needed to participate in a clinical research study evaluating Abatacept and Placebo for the treatment of Diffuse Cutaneous Systemic Sclerosis

Boston Massachusetts 02118

Patients are needed to participate in a clinical research study evaluating Abatacept and Placebo for the treatment of Diffuse Cutaneous Systemic Sclerosis

Michigan

Ann Arbor Michigan 48109

Patients are needed to participate in a clinical research study evaluating Abatacept and Placebo for the treatment of Diffuse Cutaneous Systemic Sclerosis

Minnesota

Minneapolis Minnesota 55455

Patients are needed to participate in a clinical research study evaluating Abatacept and Placebo for the treatment of Diffuse Cutaneous Systemic Sclerosis

Rochester Minnesota 55905

Patients are needed to participate in a clinical research study evaluating Abatacept and Placebo for the treatment of Diffuse Cutaneous Systemic Sclerosis

Missouri

The Lung Research Center
Chesterfield Missouri 63017

A double blind, randomised, placebo-controlled trial evaluating efficacy and safety of oral nintedanib treatment for at least 52 weeks in patients with ‘Systemic Sclerosis associated Interstitial Lung Disease’ (SSc-ILD)

New Jersey

New Brunswick New Jersey 08831

Patients are needed to participate in a clinical research study evaluating Abatacept and Placebo for the treatment of Diffuse Cutaneous Systemic Sclerosis

New York

The Rockefeller University Hospital
New York New York 10065

A proposal to search for evidence of active platelet-derived TGF-ß1 and its impact on leukocytes in Systemic Sclerosis

View More ▼

Great Neck New York 11021

Patients are needed to participate in a clinical research study evaluating Abatacept and Placebo for the treatment of Diffuse Cutaneous Systemic Sclerosis

New York New York 10021

Patients are needed to participate in a clinical research study evaluating Abatacept and Placebo for the treatment of Diffuse Cutaneous Systemic Sclerosis

New York New York 10032

Patients are needed to participate in a clinical research study evaluating Abatacept and Placebo for the treatment of Diffuse Cutaneous Systemic Sclerosis

Ohio

Cleveland Ohio 44195

Patients are needed to participate in a clinical research study evaluating Abatacept and Placebo for the treatment of Diffuse Cutaneous Systemic Sclerosis

Columbus Ohio 43221

Patients are needed to participate in a clinical research study evaluating Abatacept and Placebo for the treatment of Diffuse Cutaneous Systemic Sclerosis

Pennsylvania

Philadelphia Pennsylvania 19104

Patients are needed to participate in a clinical research study evaluating Abatacept and Placebo for the treatment of Diffuse Cutaneous Systemic Sclerosis

Pittsburgh Pennsylvania 15261

Patients are needed to participate in a clinical research study evaluating Abatacept and Placebo for the treatment of Diffuse Cutaneous Systemic Sclerosis

South Carolina

UPDATED

Charleston South Carolina 29403

A clinical research study of Oral Ifetroban and Oral Placebo

Charleston South Carolina 29425

Patients are needed to participate in a clinical research study evaluating Abatacept and Placebo for the treatment of Diffuse Cutaneous Systemic Sclerosis

Texas

Metroplex Clinical Research Center
Dallas Texas 75231

A phase 3, randomized, placebo-controlled study to assess the efficacy and safety of an investigational medication versus placebo in patients with systemic sclerosis

View More ▼

Houston Texas 77030

Patients are needed to participate in a clinical research study evaluating Abatacept and Placebo for the treatment of Diffuse Cutaneous Systemic Sclerosis

Utah

Salt Lake City Utah 84132

Patients are needed to participate in a clinical research study evaluating Abatacept and Placebo for the treatment of Diffuse Cutaneous Systemic Sclerosis

Washington

Seattle Washington 98122

Patients are needed to participate in a clinical research study evaluating Abatacept and Placebo for the treatment of Diffuse Cutaneous Systemic Sclerosis

Canada

London Ontario N6A4V2

Patients are needed to participate in a clinical research study evaluating Abatacept and Placebo for the treatment of Diffuse Cutaneous Systemic Sclerosis

Montreal Quebec H3T 1E2

Patients are needed to participate in a clinical research study evaluating Abatacept and Placebo for the treatment of Diffuse Cutaneous Systemic Sclerosis

Toronto Ontario M5T 3L9

Patients are needed to participate in a clinical research study evaluating Abatacept and Placebo for the treatment of Diffuse Cutaneous Systemic Sclerosis

France

Bordeaux 33076

A clinical trial seeking patients for a research study for the treatment of Scleroderma, Diffuse or Diffuse Cutaneous Systemic Sclerosis

Lille 59037

A clinical trial seeking patients for a research study for the treatment of Scleroderma, Diffuse or Diffuse Cutaneous Systemic Sclerosis

Montpellier 34295

A clinical trial seeking patients for a research study for the treatment of Scleroderma, Diffuse or Diffuse Cutaneous Systemic Sclerosis

Montpellier 34295

A clinical trial seeking patients for a research study for the treatment of Scleroderma, Diffuse or Diffuse Cutaneous Systemic Sclerosis

Paris 75014

A clinical trial seeking patients for a research study for the treatment of Scleroderma, Diffuse or Diffuse Cutaneous Systemic Sclerosis

View More ▼

Strasbourg 67098

A clinical trial seeking patients for a research study for the treatment of Scleroderma, Diffuse or Diffuse Cutaneous Systemic Sclerosis

Germany

Bad Nauheim 61231

A clinical trial seeking patients for a research study for the treatment of Scleroderma, Diffuse or Diffuse Cutaneous Systemic Sclerosis

Berlin

A clinical trial seeking patients for a research study for the treatment of Scleroderma, Diffuse or Diffuse Cutaneous Systemic Sclerosis

Berlin 10117

A clinical trial seeking patients for a research study for the treatment of Scleroderma, Diffuse or Diffuse Cutaneous Systemic Sclerosis

Cologne 50931

A clinical trial seeking patients for a research study for the treatment of Scleroderma, Diffuse or Diffuse Cutaneous Systemic Sclerosis

Dresden 01307

A clinical trial seeking patients for a research study for the treatment of Scleroderma, Diffuse or Diffuse Cutaneous Systemic Sclerosis

View More ▼

Erlangen 91054

A clinical trial seeking patients for a research study for the treatment of Scleroderma, Diffuse or Diffuse Cutaneous Systemic Sclerosis

Frankfurt

A clinical trial seeking patients for a research study for the treatment of Scleroderma, Diffuse or Diffuse Cutaneous Systemic Sclerosis

Freiburg 79106

A clinical trial seeking patients for a research study for the treatment of Scleroderma, Diffuse or Diffuse Cutaneous Systemic Sclerosis

Munster 48149

A clinical trial seeking patients for a research study for the treatment of Scleroderma, Diffuse or Diffuse Cutaneous Systemic Sclerosis

Ulm 89081

A clinical trial seeking patients for a research study for the treatment of Scleroderma, Diffuse or Diffuse Cutaneous Systemic Sclerosis

Italy

Ancona 60020

A clinical trial seeking patients for a research study for the treatment of Scleroderma, Diffuse or Diffuse Cutaneous Systemic Sclerosis

Brescia 25123

A clinical trial seeking patients for a research study for the treatment of Scleroderma, Diffuse or Diffuse Cutaneous Systemic Sclerosis

Firenze 50139

A clinical trial seeking patients for a research study for the treatment of Scleroderma, Diffuse or Diffuse Cutaneous Systemic Sclerosis

L'Aquila 67100

A clinical trial seeking patients for a research study for the treatment of Scleroderma, Diffuse or Diffuse Cutaneous Systemic Sclerosis